A great work from home tip is you should wear work clothes, not pyjamas to put you in a working mindset. I like to take that one step further and wear my goblin outfit, paint myself green and then I imagine if I don't do my daily goblin tasks I'll be punished by the Goblin King
We have opportunities for health economists on our expert committees. If you have experience and a desire to help power evidence-informed decisions, please consider applying by April 24. Learn more 👉 https://t.co/8GiRSVYZLi
#healtheconomics#HTA
Just released in the latest issue of @hptjournal, our paper about climate change, health services, & the importance of considering the climate in healthcare decision-making.
Co-authors: @colinscl, @hellohaldane, @AnnaCR_Studies, @dctoccs
🌎🌎🌎🌎
https://t.co/9Iu3lHrD8N
We are hiring! Scientific Director (part-time up to 0.5 FTE). Help lead meaningful work and make a difference in BC's health research community. https://t.co/pKv5ZKCXBf
Our first event for 2023 is happening on March 17th!
The topic is ‘Health economics and outcomes research considerations for Indigenous populations’. The event will be a webinar in collaboration with ISPOR UBC.
Register using the link below ⬇️⬇️
https://t.co/XRbH0KpdTh
Someone from Ireland talking about supporting two-tier care - despite Ireland having terrible wait times. Two-tier health care does not seem to cure the problem of wait times https://t.co/PHVCPJdgNS
@CADTH_ACMTS is looking for an experienced health economist with expertise in decision modeling to join our great #healtheconomics team. Help shape and protect the Canadian public health care system with me!
https://t.co/fCptOlZq3M
(Please RT)
🚨 Job alert! 🚨
Two great opportunities within the soon to launch Canadian Cancer Real-World Evaluation (CCRE) platform!
Manager, Provincial Drug Reimbursement Programs: https://t.co/ajoMOEOkVx
Operations Lead: https://t.co/OwTaBMBZhx
@CC_ARCC@OntarioHealthOH @CADTH_ACMTS
Excited to see an editorial authored by myself & @akesselheim published in @bmj_latest!
We discuss the implications of an important paper by @FengtasticXie & Zhou on industry bias in cost-effectiveness analyses.
Editorial: https://t.co/gqUW0YGuOq
Paper: https://t.co/4HV8PlxpF6
So honored to have U.S. Rep. @LaurenUnderwood - a @JohnsHopkinsSPH alum - speak to recent graduates.
In her words: "The magnitude of the crises before us can be overwhelming. The antidote is community."
Thank you for the inspiration & for celebrating #ThePowerofPublicHealth.
Just learned that a cost-effectiveness model I built in 2019 has finally made its way into the literature!
https://t.co/Eo9AmHMy9O
We used the model to estimate the cost-effectiveness of cell-of-origin subtype guided treatment in #DLBCL
The model was built in #rstats and based on retrospective EMR data and estimates from the PHOENIX trial. It allowed us to evaluate #ibrutinib in both the first- and second-line setting, based on molecular subtyping through the use of an assay.
Thank you all who came to our event today! If you’re interested in patient and public involvement & transparency in modelling, check out the talks on YouTube, including from health economist @HlthyUncert & philosopher Kevin Elliott! @HlthResearchBC @PeerModels